HoneyPower Disclaimer

The overview panel carries this sentence, and it travels to every page of this website verbatim because it is printed on the product itself:

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.Printed on the HoneyPower overview panel

Three things follow from it and all three are worth stating rather than assuming. HoneyPower is a dietary supplement, not a drug. It is not FDA-approved, because dietary supplements are not approved by the Food and Drug Administration in the way medicines are. And it is not intended to diagnose, treat, cure or prevent any disease, which means no sentence on this site may describe it as doing so.

That last point is the ceiling every page here is written against. The nine benefit lines on the overview panel are structure and function statements about a healthy adult man, each carrying an asterisk on the artwork pointing at the sentence above. They are the most this product may claim and they are quoted here as the seller’s wording rather than restated as effects.

Seven rows. The last three are the ones that separate this site from a sales page.

The refusals cost something and they are made anyway. A testosterone claim would sell more capsules than a row explaining that tribulus was given directly to young men and measured with no change in androgen production, and the survey of best-selling testosterone boosters found 46 per cent of the human studies behind this category’s ten commonest ingredients reported no effect at all.

This is the part of a supplement site that usually gets said five times in five different places. It is said once here, in full, on the page whose subject it is.

Erectile difficulty and persistent fatigue are both worth having assessed rather than supplemented. The reason is not caution for its own sake: both can be the first presentation of something a capsule has no bearing on, and both are things a doctor can investigate quickly. The American Urological Association’s guideline sets out what an assessment involves, and the Endocrine Society’s guideline is explicit that low testosterone is diagnosed on morning blood draws repeated on separate days rather than on how a man feels at four in the afternoon.

There are two specific conversations worth having before the first capsule rather than after the first bottle. Anyone on warfarin or another anticoagulant should raise Panax ginseng by name, because a randomised trial measured American ginseng reducing warfarin’s effect at one gram twice daily. Anyone taking a medicine cleared by CYP3A4 should raise black pepper extract, because piperine inhibits that enzyme and P-glycoprotein and cannot tell a nutrient from a tablet.

Every paper cited here was verified live in the session that wrote the page, and the amount each trial actually gave was read off the record rather than recalled. That is the easy half. The harder half is what a citation is allowed to be used for.

The rule is that a trial is evidence about what the trial gave. A twelve-week trial of Korean red ginseng at three grams a day is evidence about three grams a day of Korean red ginseng. It is not evidence about a capsule containing an unstated quantity of ginseng alongside five other plants, and no sentence on this site treats it as though it were.

That is why the ingredients page sets trial doses beside an empty label column instead of merging the two. The comparison a reader would want cannot be completed, and a site that completes it anyway has invented the missing half.

Four rows. The third is the one every supplement page in this category gets wrong.

• A dietary supplement, not a drug. It comes as a capsule, not a gummy and not liquid drops.
• Not intended to diagnose, treat, cure or prevent any disease, and not FDA-approved.
• For healthy adult men aged 18 and over. Not for anyone under 18, and not for women who are pregnant or nursing.
• “Male enhancement” is wording printed on the bottle. This desk quotes it as label text and does not restate it as an effect.
• The artwork names six ingredients and gives an amount for none of them, so no milligram figure for this product appears anywhere on this website.
• Ginseng has a measured interaction with warfarin: 1 g twice daily reduced its effect in a randomised trial. Anyone on an anticoagulant should raise it with their prescriber before starting.
• Piperine, the active in black pepper extract, inhibits CYP3A4 and P-glycoprotein. The mechanism that lifts a nutrient’s blood level lifts a medicine’s too.
• Erectile difficulty and persistent fatigue are worth having assessed once. Both can be the first sign of something a capsule has no bearing on.
• Individual results vary. Sleep, alcohol, weight, blood pressure and medication all act on the same things this formula is sold for.
• The star score and order count shown on Myhoneypower come from the distributor’s own summary; they are not checked transcripts and they do not show that the capsule works.
• Lot HON-26/MY-5579 and certificate reference HON-5579-26-MY are filing references, not laboratory proof.
• The website email cannot see orders. For a refund, call the order desk or write to the sales address.
• The money-back guarantee covers your purchase; it makes no promise about results.

That list is the site’s complete set of qualifications, collected in one place on purpose. A caveat repeated in every section is what makes a page unreadable; the same fact stated once, in the section whose job it is, is what makes it useful.

Myhoneypower is the U.S. stocking partner for HoneyPower. It earns when somebody buys through the seller’s checkout, and every call to action on this site points at that checkout. That is a commercial interest and a reader is entitled to know about it before weighing anything else here.

What this desk does about it is publish the things that cost it money. The review figures on this site are the distributor’s lower set rather than the seller’s higher one. The testosterone claim is refused. The circulation claim is refused. No milligram figure is printed for a product whose artwork prints none, and no delivery estimate is invented for a pack that publishes none.

None of that makes the commercial interest disappear. It does mean a reader can check whether the interest has been allowed to write the pages, which is the only test that matters.